NDC Pharmacologic Class N0000191275 UGT1A3 Inhibitors [MoA]
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 0007-4640 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Glaxosmithkline Llc | Human Prescription Drug |
| 0007-4641 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Glaxosmithkline Llc | Human Prescription Drug |
| 0007-4643 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Glaxosmithkline Llc | Human Prescription Drug |
| 0078-0684 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0078-0685 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0078-0686 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0078-0687 | Promacta | Eltrombopag Olamine | Tablet, Film Coated | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0078-0972 | Promacta | Eltrombopag Olamine | Powder, For Suspension | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
There are 8 NDC products with the pharmacologic class UGT1A3 Inhibitors [MoA].